Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lu Zhou, Huiping Shi, Wenyu Shi, Li Yang, Yaping Zhang, Mengqi Xu, Xiufang Chen, Yanv Zhu, Hui Mu, Xiaochun Wan, Zhonghua Yang, Ying Zeng & Hong Liu. (2019) Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy. OncoTargets and Therapy 12, pages 10989-10995.
Read now
Read now
Kellsye Paula L. Fabian, Nina Chi-Sabins, Jennifer L. Taylor, Ronald Fecek, Aliyah Weinstein & Walter J. Storkus. (2017) Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice. OncoImmunology 6:3.
Read now
Read now
Jennifer D. Elster, Deepa K. Krishnadas & Kenneth G. Lucas. (2016) Dendritic cell vaccines: A review of recent developments and their potential pediatric application. Human Vaccines & Immunotherapeutics 12:9, pages 2232-2239.
Read now
Read now
Dàlia Raïch-Regué, Kellsye P. Fabian, Alicia R. Watson, Ronald J. Fecek, Walter J. Storkus & Angus W. Thomson. (2016) Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8+ effector T cell responses. OncoImmunology 5:6.
Read now
Read now
Norma Bloy, Jonathan Pol, Fernando Aranda, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fučíková, Jérôme Galon, Eric Tartour, Radek Spisek, Madhav V. Dhodapkar, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: Dendritic cell-based anticancer therapy. OncoImmunology 3:11.
Read now
Read now
Articles from other publishers (27)
Erick J. Carlson, Himanshu Savardekar, Xiaojun Hu, Gabriella Lapurga, Courtney Johnson, Steven H. Sun, William E. Carson & Blake R. Peterson. (2023) Fluorescent Detection of Peroxynitrite Produced by Myeloid-Derived Suppressor Cells in Cancer and Inhibition by Dasatinib. ACS Pharmacology & Translational Science 6:5, pages 738-747.
Crossref
Crossref
María Luisa Sánchez-León, Carlos Jiménez-Cortegana, Gabriel Cabrera, Elba Mónica Vermeulen, Luis de la Cruz-Merino & Victor Sánchez-Margalet. (2022) The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells. Frontiers in Immunology 13.
Crossref
Crossref
Kalliopi Domvri, Savvas Petanidis, Paul Zarogoulidis, Doxakis Anestakis, Charalampos Charalampidis, Drosos Tsavlis, Haidong Huang, Lutz Freitag, Wolfgang Hohenforst-Schmidt, Dimitris Matthaios, Theodora Katopodi & Konstantinos Porpodis. (2022) Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity. International Journal of Nanomedicine Volume 17, pages 4449-4468.
Crossref
Crossref
Paul V. Munson, Lisa H. Butterfield & Juraj Adamik. 2022. Cancer Vaccines as Immunotherapy of Cancer. Cancer Vaccines as Immunotherapy of Cancer
109
135
.
Walter J Storkus, Deena Maurer, Yan Lin, Fei Ding, Anamika Bose, Devin Lowe, Amy Rose, Melissa DeMark, Lilit Karapetyan, Jennifer L Taylor, Manoj Chelvanambi, Ronald J Fecek, Jessica N Filderman, Timothy J Looney, Lauren Miller, Elizabeth Linch, Geoffrey M Lowman, Pawel Kalinski, Lisa H Butterfield, Ahmad Tarhini, Hussein Tawbi & John M Kirkwood. (2021) Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma. Journal for ImmunoTherapy of Cancer 9:11, pages e003675.
Crossref
Crossref
David A. Close, John M. Kirkwood, Ronald J. Fecek, Walter J. Storkus & Paul A. Johnston. (2021) Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell Lines. SLAS Discovery 26:5, pages 712-729.
Crossref
Crossref
Jun-Yan Li, Yu-Pei Chen, Ying-Qin Li, Na Liu & Jun Ma. (2021) Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades. Molecular Cancer 20:1.
Crossref
Crossref
Amanda L. Wooster, Lydia H. Girgis, Hayley Brazeale, Trevor S. Anderson, Laurence M. Wood & Devin B. Lowe. (2021) Dendritic cell vaccine therapy for colorectal cancer. Pharmacological Research 164, pages 105374.
Crossref
Crossref
Mahsa Sadeghzadeh, Soghra Bornehdeli, Haniye Mohahammadrezakhani, Mahsa Abolghasemi, Elham Poursaei, Milad Asadi, Venus Zafari, Leili Aghebati-Maleki & Dariush Shanehbandi. (2020) Dendritic cell therapy in cancer treatment; the state-of-the-art. Life Sciences 254, pages 117580.
Crossref
Crossref
Yuhui Yang, Chunyan Li, Tao Liu, Xiaofang Dai & Alexandr V. Bazhin. (2020) Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Frontiers in Immunology 11.
Crossref
Crossref
Alice Barbarin, Myriam Abdallah, Lucie Lefèvre, Nathalie Piccirilli, Emilie Cayssials, Lydia Roy, Jean-Marc Gombert & André Herbelin. (2020) Innate T-αβ lymphocytes as new immunological components of anti-tumoral “off-target” effects of the tyrosine kinase inhibitor dasatinib. Scientific Reports 10:1.
Crossref
Crossref
Zhida Liu, Chuanhui Han & Yang-Xin Fu. (2019) Targeting innate sensing in the tumor microenvironment to improve immunotherapy. Cellular & Molecular Immunology 17:1, pages 13-26.
Crossref
Crossref
Thiago A. Patente, Mariana P. Pinho, Aline A. Oliveira, Gabriela C. M. Evangelista, Patrícia C. Bergami-Santos & José A. M. Barbuto. (2019) Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. Frontiers in Immunology 9.
Crossref
Crossref
Domenico Galati & Serena Zanotta. (2018) Empowering dendritic cell cancer vaccination: the role of combinatorial strategies. Cytotherapy 20:11, pages 1309-1323.
Crossref
Crossref
Cassiano Felippe Gonçalves-de-Albuquerque, Ina Rohwedder, Adriana Ribeiro Silva, Alessandra Silveira Ferreira, Angela R. M. Kurz, Céline Cougoule, Sarah Klapproth, Tanja Eggersmann, Johnatas D. Silva, Gisele Pena de Oliveira, Vera Luiza Capelozzi, Gabriel Gutfilen Schlesinger, Edlaine Rijo Costa, Rita de Cassia Elias Estrela Marins, Attila Mócsai, Isabelle Maridonneau-Parini, Barbara Walzog, Patricia Rieken Macedo Rocco, Markus Sperandio & Hugo Caire de Castro-Faria-Neto. (2018) The Yin and Yang of Tyrosine Kinase Inhibition During Experimental Polymicrobial Sepsis. Frontiers in Immunology 9.
Crossref
Crossref
Carole Fournier, Thaiz Rivera Vargas, Tiffany Martin, Andréa Melis & Lionel Apetoh. (2017) Immunotherapeutic properties of chemotherapy. Current Opinion in Pharmacology 35, pages 83-88.
Crossref
Crossref
Can Hekim, Mette Ilander, Jun Yan, Erin Michaud, Richard Smykla, Markus Vähä-Koskela, Paula Savola, Siri Tähtinen, Leena Saikko, Akseli Hemminki, Panu E. Kovanen, Kimmo Porkka, Francis Y.F. Lee & Satu Mustjoki. (2017) Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models. Cancer Immunology Research 5:2, pages 157-169.
Crossref
Crossref
Lakshmi Jayashankar & Richard Hafner. (2016) Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination. Frontiers in Immunology 7.
Crossref
Crossref
Ahmad A Tarhini, Hussein Tawbi & Walter J Storkus. (2016) Vaccine therapy + dasatinib for the treatment of patients with stage IIIB–IV melanoma. Melanoma Management 3:4, pages 251-254.
Crossref
Crossref
Lorenzo Galluzzi, Laurence Zitvogel & Guido Kroemer. (2016) Immunological Mechanisms Underneath the Efficacy of Cancer Therapy. Cancer Immunology Research 4:11, pages 895-902.
Crossref
Crossref
Ronald J Fecek & Walter J Storkus. (2016) Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines. Immunotherapy 8:10, pages 1205-1218.
Crossref
Crossref
Annkristin Heine, Judith Schilling, Barbara Grünwald, Achim Krüger, Heidrun Gevensleben, Stefanie Andrea Erika Held, Natalio Garbi, Christian Kurts, Peter Brossart, Percy Knolle, Linda Diehl & Bastian Höchst. (2016) The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib. Cancer Immunology, Immunotherapy 65:3, pages 273-282.
Crossref
Crossref
Chris G. TwittyOscar R. DiagoDaniel J. HoganCindy BurrascanoCarlos E. IbanezDouglas J. JollyDerek Ostertag. (2016) Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types. Human Gene Therapy Methods 27:1, pages 17-31.
Crossref
Crossref
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel & Guido Kroemer. (2015) Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell 28:6, pages 690-714.
Crossref
Crossref
Jashodeep Datta, Erik Berk, Jessica A. Cintolo, Shuwen Xu, Robert E. Roses & Brian J. Czerniecki. (2015) Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy. Frontiers in Immunology 6.
Crossref
Crossref
Lisa Christiansson, Stina Söderlund, Sara Mangsbo, Henrik Hjorth-Hansen, Martin Höglund, Berit Markevärn, Johan Richter, Leif Stenke, Satu Mustjoki, Angelica Loskog & Ulla Olsson-Strömberg. (2015) The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses. Molecular Cancer Therapeutics 14:5, pages 1181-1191.
Crossref
Crossref
Mariana Aris & MarÃa Marcela Barrio. (2015) Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment. Frontiers in Immunology 6.
Crossref
Crossref